Immediate Impact
1 by Nobel laureates 1 from Science/Nature 44 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Bryan Li being referenced
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
2021
Chemotherapy induces NEDP1-mediated destabilization of MDM2
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bryan Li | 39 | 83 | 67 | 18 | 180 | |
| Angelo Dipasquale | 70 | 51 | 64 | 23 | 196 | |
| Wen‐Shuo Wu | 17 | 73 | 82 | 18 | 260 | |
| Robert Welschinger | 25 | 90 | 60 | 16 | 282 | |
| Sho Kurihara | 12 | 79 | 77 | 18 | 179 | |
| Lin Yang | 12 | 55 | 150 | 22 | 231 | |
| Fiona E. Scott | 12 | 38 | 101 | 19 | 204 | |
| Minh Tran | 58 | 80 | 138 | 13 | 253 | |
| Hilda Haynes | 12 | 54 | 143 | 20 | 271 | |
| Nicholas Coupe | 16 | 66 | 132 | 19 | 207 | |
| Stan Gill | 32 | 41 | 62 | 13 | 149 |
All Works
Login with ORCID to disown or claim papers
Loading papers...